 Home > Active Ingredient News > Blood System > Lancet Haematol: ibethromide plus dexamethasone for severely pretreated late relapsed or refractory multiple myeloma

Lancet Haematol: ibethromide plus dexamethasone for severely pretreated late relapsed or refractory multiple myeloma

 Last Update: 2022-10-19
 Source: Internet
 Author: User

Tags

formaldehyde phase 2

dig 6 3

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Original source:

Lonial S, Popat R, Hulin C, et al.
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial [published online ahead of print, 2022 Oct 6].
Lancet Haematol.
2022; S2352-3026(22)00290-3.
doi:10.
1016/S2352-3026(22)00290-3

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gadusol Powder Gadusol76663-30-4

CAS No.: 76663-30-4

Industrial Grade

$1-1.01/G FOB

Food Additive Iron fumarate for Nutritional Iron Supplements

CAS No.: 141-01-5

Pharmacy Grade

$24-26/G FOB

Aminobenzoic Acid CAS 56-91-7

CAS No.: 56-91-7

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.